A case report about recurrent BRAF V600E-mutant adult gliomas [41] found that after a failure of a BRAF inhibitor alone, a BRAF inhibitor combined with a MEK inhibitor could exert a markedly prolonging OS. The gene discussed is MAP2K7; the disease is central nervous system cancer.